{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:23:00Z","timestamp":1789986180164,"version":"4.0.1"},"reference-count":32,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,3]]},"DOI":"10.18632\/oncotarget.13518","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T12:18:28Z","timestamp":1479903508000},"page":"979-987","source":"Crossref","is-referenced-by-count":22,"title":["Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling"],"prefix":"10.18632","volume":"8","author":[{"given":"Yuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children's Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children's Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children's Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Children's Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,23]]},"reference":[{"key":"1","article-title":"Systematic review and meta-analysis of human milk intake and retinopathy of prematurity: a significant update","author":"Dhanireddy","year":"2016","journal-title":"J Perinatol"},{"key":"2","first-page":"228","article-title":"Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options","volume":"6","author":"Sarici","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Dammann","year":"2013","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0000000000000270","article-title":"Natural history of retinopathy of prematurity: two-year outcomes of a prospective study","volume":"35","author":"Wu","year":"2015","journal-title":"Retina"},{"key":"5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/17.suppl_9.65","article-title":"Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy","volume":"17","author":"Brady","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"6","doi-asserted-by":"publisher","first-page":"35353","DOI":"10.18632\/oncotarget.9286","article-title":"Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist","volume":"7","author":"Mitola","year":"2016","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1042\/BCJ20160254","article-title":"Structure of Gremlin-1 and analysis of its interaction with BMP-2","volume":"473","author":"Hyvonen","year":"2016","journal-title":"Biochem J"},{"key":"8","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s13277-015-4093-8","article-title":"Overexpression of Gremlin promotes non-small cell lung cancer progression","volume":"37","author":"Qu","year":"2016","journal-title":"Tumour Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exer.2007.11.016","article-title":"Focus on molecules: gremlin","volume":"87","author":"Clark","year":"2008","journal-title":"Exp Eye Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"31635","DOI":"10.1074\/jbc.M113.477745","article-title":"Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE\u2212\/\u2212 Mice","volume":"288","author":"Fahrleitner","year":"2013","journal-title":"J Biol Chem"},{"key":"11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exer.2013.05.011","article-title":"Gremlin utilizes canonical and non-canonical TGFbeta signaling to induce lysyl oxidase (LOX) genes in human trabecular meshwork cells","volume":"113","author":"Clark","year":"2013","journal-title":"Exp Eye Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.111.038125","article-title":"Gremlin plays a key role in the pathogenesis of pulmonary hypertension","volume":"125","author":"McLoughlin","year":"2012","journal-title":"Circulation"},{"key":"13","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","article-title":"Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2","volume":"116","author":"Presta","year":"2010","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Claesson-Welsh","year":"2006","journal-title":"Exp Cell Res"},{"key":"15","article-title":"Tumor necrosis factor-alpha (TNF-alpha)-mediated in vitro human retinal pigment epithelial (RPE) cell migration mainly requires Akt\/mTOR complex 1 (mTORC1), but not mTOR complex 2 (mTORC2) signaling","author":"Yao","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"16","first-page":"29","article-title":"Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent","volume":"15","author":"Cherrington","year":"2000","journal-title":"Anticancer Drug Des"},{"key":"17","first-page":"1093","article-title":"Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation","volume":"2","author":"Roy","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/leu.2011.339","article-title":"The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia","volume":"26","author":"Moura","year":"2012","journal-title":"Leukemia"},{"key":"19","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/1535-7163.MCT-10-1099","article-title":"Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin","volume":"10","author":"Pachter","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"20","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1038\/onc.2010.139","article-title":"Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy","volume":"29","author":"Guertin","year":"2010","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.06.017","article-title":"mTOR kinase inhibitors as potential cancer therapeutic drugs","volume":"340","author":"Sun","year":"2013","journal-title":"Cancer Lett"},{"key":"22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ijc.28023","article-title":"Targeting PI3K and mTORC2 in metastatic renal cell carcinoma: new strategies for overcoming resistance to VEGFR and mTORC1 inhibitors","volume":"133","author":"Brechbiel","year":"2013","journal-title":"Int J Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrc1974","article-title":"mTOR and cancer: insights into a complex relationship","volume":"6","author":"Sabatini","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4161\/auto.5.5.8507","article-title":"RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia","volume":"5","author":"Bendall","year":"2009","journal-title":"Autophagy"},{"key":"25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Sabatini","year":"2007","journal-title":"Cancer Cell"},{"key":"26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"29415","DOI":"10.1038\/srep29415","article-title":"Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2alpha expression and cell proliferation","volume":"6","author":"Pan","year":"2016","journal-title":"Sci Rep"},{"key":"28","first-page":"CD009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"2","author":"Srinivasan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jash.2013.03.002","article-title":"ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice","volume":"7","author":"Horiuchi","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3233\/JAD-121636","article-title":"Neurovascular unit and the effects of dosage in VEGF toxicity: role for oxidative stress and thrombin","volume":"34","author":"Grammas","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"31","doi-asserted-by":"crossref","first-page":"31549","DOI":"10.1074\/jbc.M701317200","article-title":"Conditional deletion of gremlin causes a transient increase in bone formation and bone mass","volume":"282","author":"Canalis","year":"2007","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T13:26:12Z","timestamp":1589117172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,3]]}},"alternative-id":["13518","27894090"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13518","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,23]]}}}